Northern Trust’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Sell |
362,518
-11,135
| -3% | -$37.5K | ﹤0.01% | 3281 |
|
|
2025
Q1 | $1.44M | Sell |
373,653
-14,472
| -4% | -$55.9K | ﹤0.01% | 3102 |
|
|
2024
Q4 | $2.39M | Buy |
388,125
+51,351
| +15% | +$317K | ﹤0.01% | 2919 |
|
|
2024
Q3 | $1.81M | Sell |
336,774
-571
| -0.2% | -$3.07K | ﹤0.01% | 3062 |
|
|
2024
Q2 | $1.13M | Sell |
337,345
-19,939
| -6% | -$66.8K | ﹤0.01% | 3193 |
|
|
2024
Q1 | $1.44M | Sell |
357,284
-15,643
| -4% | -$63K | ﹤0.01% | 3143 |
|
|
2023
Q4 | $988K | Buy |
372,927
+49,668
| +15% | +$132K | ﹤0.01% | 3322 |
|
|
2023
Q3 | $763K | Sell |
323,259
-1,479
| -0.5% | -$3.49K | ﹤0.01% | 3380 |
|
|
2023
Q2 | $2.05M | Buy |
324,738
+48,970
| +18% | +$309K | ﹤0.01% | 2993 |
|
|
2023
Q1 | $1.59M | Sell |
275,768
-3,362
| -1% | -$19.4K | ﹤0.01% | 3035 |
|
|
2022
Q4 | $2.86M | Sell |
279,130
-4,565
| -2% | -$46.8K | ﹤0.01% | 2801 |
|
|
2022
Q3 | $4.74M | Buy |
283,695
+25,673
| +10% | +$429K | ﹤0.01% | 2521 |
|
|
2022
Q2 | $3.61M | Buy |
258,022
+46,988
| +22% | +$658K | ﹤0.01% | 2713 |
|
|
2022
Q1 | $3.41M | Sell |
211,034
-981
| -0.5% | -$15.8K | ﹤0.01% | 2806 |
|
|
2021
Q4 | $4.54M | Buy |
212,015
+89,183
| +73% | +$1.91M | ﹤0.01% | 2742 |
|
|
2021
Q3 | $1.8M | Sell |
122,832
-12,695
| -9% | -$186K | ﹤0.01% | 3345 |
|
|
2021
Q2 | $2.7M | Buy |
+135,527
| New | +$2.7M | ﹤0.01% | 3214 |
|